Why the study?
Does a two-visit strategy compared to a single-visit strategy improve the accuracy of hypertension prevalence estimation in a general population?
Does a two-visit strategy compared to a single-visit strategy improve the accuracy of hypertension prevalence estimation in a general population?
Using a two-visit strategy for hypertension diagnosis reduces the estimated prevalence by 35% compared to a single visit, safely excluding low-risk individuals and potentially optimizing healthcare resource allocation.
No takes yet. Share an insight, caveat, or question.
Single-visit hypertension screening may overestimate prevalence; challenges epidemiological norms and leaves two-visit adoption open pending prospective validation.
Modesti et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: